S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.84 (-11.52%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)
S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.84 (-11.52%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)
S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.84 (-11.52%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)
S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.84 (-11.52%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)
NASDAQ:AFYA

Afya (AFYA) Stock Price, News & Analysis

$18.76
+0.13 (+0.70%)
(As of 09:41 AM ET)
Today's Range
$18.70
$18.77
50-Day Range
$18.73
$22.37
52-Week Range
$10.19
$22.48
Volume
3,581 shs
Average Volume
129,487 shs
Market Capitalization
$1.76 billion
P/E Ratio
21.81
Dividend Yield
N/A
Price Target
$23.00

Afya MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
23.5% Upside
$23.00 Price Target
Short Interest
Bearish
3.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.46mentions of Afya in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.99%
From $1.54 to $1.74 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.38 out of 5 stars

Consumer Discretionary Sector

172nd out of 273 stocks

Educational Services Industry

17th out of 21 stocks

AFYA stock logo

About Afya Stock (NASDAQ:AFYA)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

AFYA Stock Price History

AFYA Stock News Headlines

The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
Afya Is Performing Well And Is A Buy
the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Unveiling the secrets of Mafia Island
See More Headlines
Receive AFYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Afya and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/26/2021
Today
3/28/2024
Next Earnings (Estimated)
5/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Educational services
Sub-Industry
N/A
Current Symbol
NASDAQ:AFYA
Fax
N/A
Employees
8,708
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$23.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+22.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$77.38 million
Pretax Margin
14.94%

Debt

Sales & Book Value

Annual Sales
$576.09 million
Cash Flow
$1.78 per share
Book Value
$7.79 per share

Miscellaneous

Free Float
92,973,000
Market Cap
$1.76 billion
Optionable
Optionable
Beta
0.98
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

AFYA Stock Analysis - Frequently Asked Questions

Should I buy or sell Afya stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Afya in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AFYA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFYA, but not buy additional shares or sell existing shares.
View AFYA analyst ratings
or view top-rated stocks.

What is Afya's stock price target for 2024?

3 Wall Street analysts have issued 1 year target prices for Afya's stock. Their AFYA share price targets range from $23.00 to $23.00. On average, they expect the company's stock price to reach $23.00 in the next year. This suggests a possible upside of 23.5% from the stock's current price.
View analysts price targets for AFYA
or view top-rated stocks among Wall Street analysts.

How have AFYA shares performed in 2024?

Afya's stock was trading at $21.93 on January 1st, 2024. Since then, AFYA stock has decreased by 15.0% and is now trading at $18.63.
View the best growth stocks for 2024 here
.

Are investors shorting Afya?

Afya saw a increase in short interest in March. As of March 15th, there was short interest totaling 646,200 shares, an increase of 23.0% from the February 29th total of 525,300 shares. Based on an average trading volume of 130,500 shares, the days-to-cover ratio is currently 5.0 days. Approximately 3.6% of the company's stock are short sold.
View Afya's Short Interest
.

When is Afya's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024.
View our AFYA earnings forecast
.

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) announced its quarterly earnings results on Wednesday, May, 26th. The company reported $1.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.56 by $0.40. The company had revenue of $72.15 million for the quarter, compared to the consensus estimate of $72.96 million. Afya had a trailing twelve-month return on equity of 15.88% and a net margin of 13.54%.
Read the conference call transcript
.

What ETFs hold Afya's stock?

ETFs with the largest weight of Afya (NASDAQ:AFYA) stock in their portfolio include BNY Mellon Sustainable Global Emerging Markets ETF (BKES).VanEck Brazil Small-Cap ETF (BRF).

What guidance has Afya issued on next quarter's earnings?

Afya issued an update on its FY 2024 earnings guidance on Friday, March, 15th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $635.9 million-$656.1 million, compared to the consensus revenue estimate of $633.4 million.

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Pfizer (PFE), Cisco Systems (CSCO), Procter & Gamble (PG), RTX (RTX), Abbott Laboratories (ABT), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA) and CSX (CSX).

When did Afya IPO?

Afya (AFYA) raised $233 million in an initial public offering on Friday, July 19th 2019. The company issued 13,700,000 shares at a price of $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments served as the underwriters for the IPO.

Who are Afya's major shareholders?

Afya's stock is owned by a number of retail and institutional investors. Top institutional investors include Perpetual Ltd (0.86%), Massachusetts Financial Services Co. MA (0.35%), Doma Perpetual Capital Management LLC (0.31%), FIL Ltd (0.31%), Renaissance Group LLC (0.16%) and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (0.15%).

How do I buy shares of Afya?

Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AFYA) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners